VRDN

Viridian Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$18.84

Market Cap

$1.60B

Beta

1.01

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+23359.93%

EPS Growth (YoY)+11.94%

Revenue CAGR 3Y+241.95%

P/E Ratio0.0

PEG Ratio—

FCF Yield-17.32%

Debt / Equity0.07

Interest Coverage-44.0x

No credit card required

Already have an account? Sign in to view the full analysis for VRDN.